Found 4 Enz. Inhib. hit(s) with Target = 'Receptor-type tyrosine-protein phosphatase beta' and Ligand = 'BDBM359187'
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.
US Patent
AERPIO THERAPEUTICS, INC.
US Patent
Affinity DataIC50: 0.200nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.
US Patent
AERPIO THERAPEUTICS, INC.
US Patent
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.
US Patent
AERPIO THERAPEUTICS, INC.
US Patent
Affinity DataIC50: 0.200nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.
US Patent
AERPIO THERAPEUTICS, INC.
US Patent
Affinity DataIC50: 0.200nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair